The technology landscape is rapidly evolving and leading life sciences companies are capitalizing on the opportunities created by new technologies such as AI, RPA, quantum computing, predictive analytics and blockchain. Companies can now drive unprecedented change in the way people work and live by leveraging these advances to create innovative products and services that center around the patient.
These technologies can drive significant internal transformation for the life sciences industry, but leaders are going beyond that and harnessing these capabilities to create a new, patient-centric reinvention to deliver the same digital experience to patients that they receive in other aspects of their day to day lives.
Of course, these advancements cannot function without robust, comprehensive and secure data at scale. To access all the data and tools they’ll need, life sciences CIO’s must reimagine their technology architectures to extend their enterprise into an ecosystem of partners that’s wider than ever before to create disruptions in the way business is run.
Our Life Sciences Technology Services harness these new technology capabilities and build on our partnership with industry innovators to bring industry specific solutions across all parts of the life sciences value chain.
KEY ALLIANCE PARTNERS
Investment and spending on blockchain-based technology have each topped more than $1 billion and continue to grow. Accenture’s current projections for the blockchain services market alone estimates a CAGR of more than 60 percent, hitting close to $7 billion by 2021.
Within life sciences alone blockchain technology could provide a $3 billion dollar opportunity by 2025.